Publications by authors named "Colin Zhang"

Claim this Profile
A
AI-powered printability evaluation framework for 3D bioprinting using Hausdorff distance metrics.
Colin Zhang, Kelum Chamara Manoj Lakmal Elvitigala, Shinji Sakai

Biofabrication· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toward Complete Molecular Structure Prediction from Infrared Spectroscopy Using Deep Learning.
Colin Zhang, Yang Ha

J Chem Inf Model· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physics-informed machine learning for automatic model reduction in chemical reaction networks.
Joseph Pateras, Colin Zhang, Shriya Majumdar, Ayush Pal, Preetam Ghosh

Sci Rep· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
3
3D Bioprinting of Sugar Beet Pectin through Horseradish Peroxidase-Catalyzed Cross-Linking.
Wildan Mubarok, Colin Zhang, Shinji Sakai

ACS Appl Bio Mater· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of 1'-(1-phenylcyclopropane-carbonyl)-3H-spiro[isobenzofuran-1,3'-pyrrolidin]-3-one as a novel steroid mimetic scaffold for the potent and tissue-specific inhibition of 11β-HSD1 using a scaffold-hopping approach.
Colin Zhang, Meizhong Xu, Chunhong He, Jincong Zhuo, David M Burns

Bioorg Med Chem Lett· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Novel Pyrazolopyrimidines as Potent, Selective, and Orally Bioavailable Inhibitors of ALK2.
Minh H Nguyen, Onur Atasoylu, Liangxing Wu, Kanishk Kapilashrami, Michelle Pusey, Colin Zhang

ACS Med Chem Lett· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Pemigatinib: A Potent and Selective Fibroblast Growth Factor Receptor (FGFR) Inhibitor.
Liangxing Wu, Colin Zhang, Chunhong He, Dingquan Qian, Liang Lu, Yue Zhang

J Med Chem· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Compelling P1 substituent affect on metalloprotease binding profile enables the design of a novel cyclohexyl core scaffold with excellent MMP selectivity and HER-2 sheddase inhibition.
David M Burns, Yun-Long Li, Eric Shi, Chunhong He, Meizhong Xu, Colin Zhang

Bioorg Med Chem Lett· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and identification of selective HER-2 sheddase inhibitors via P1' manipulation and unconventional P2' perturbations to induce a molecular metamorphosis.
Wenqing Yao, Jincong Zhuo, David M Burns, Yun-Long Li, Ding-Quan Qian, Colin Zhang

Bioorg Med Chem Lett· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a potent, selective, and orally active human epidermal growth factor receptor-2 sheddase inhibitor for the treatment of cancer.
Wenqing Yao, Jincong Zhuo, David M Burns, Meizhong Xu, Colin Zhang

J Med Chem· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of ADAM10 as a major source of HER2 ectodomain sheddase activity in HER2 overexpressing breast cancer cells.
Phillip C C Liu, Xiangdong Liu, Yanlong Li, Maryanne Covington, Richard Wynn, Colin Zhang

Cancer Biol Ther· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis